ArticleHeliyon2025
The effect of
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Ethnobotany, Phytochemistry, and Pharmacological Activities ofInternational journal of molecular sciences · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postpartum depression is a multifactorial and complex disorder. Various approaches for preventing and treating this condition have been suggested. Nevertheless, there is no definitive proof confirming their efficacy. This study is designed to assess the effectiveness of basil in preventing postpartum depression (primary outcome) and sleep quality (secondary outcome). Methods: This triple-blind parallel clinical trial (participants, the researcher, and the data analyst were blinded to the assigned interventions) included 78 postpartum women at Taleghani Hospital, Tabriz, Iran, between April 2023 and April 2024. Participants who scored 12 or less on the Edinburgh Postnatal Depression Scale (EPDS) were included in the study. The intervention started within 72 h following birth and continued for eight weeks postpartum. The intervention group received two daily capsules containing dried basil leaf powder, while the control group received 500 mg of starch. The EPDS and postpartum sleep quality scale were completed through structured interviews at eight weeks postpartum. The Mann-Whitney Results: The median (25th, 75th percentile) depression score after intervention in the basil and placebo groups was 1.0 (0.0, 2.0) and 1.0 (0.0, 3.0), respectively, with no statistically significant difference between the groups (p = 0.966). The mean (standard deviation) sleep quality score after the intervention in the basil and placebo groups was 17.63 (3.44) and 16.15 (3.20), respectively. There was no statistically significant difference in sleep quality scores between the basil and placebo groups (p = 0.400). Conclusion: The results show that basil does not prevent postpartum depression or improve sleep quality. Future studies should investigate the effects of basil at higher doses and in extract form.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.